SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
Analysts Say Valeant Pharmaceuticals International/Allergan Inc. Deal Could Lead To Buying Spree
September 29, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Valueact Places CEO On Valeant Pharmaceuticals International’s Board In Effort To Force Allergan Inc. Takeover
September 26, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
More Than 35% Of Allergan Inc. Investors Demand Special Meeting; Support For Valeant Merger Grows
September 12, 2014
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Allergan Inc. Loses Battle To Make Shareholder Vote Moot On Valeant Pharmaceuticals International Bid
August 22, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Allergan Inc. Approaches Salix Pharmaceuticals, Ltd. To Fend Off Valeant Pharmaceuticals International’s Hostile Bid
August 20, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Allergan Inc. CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International
August 19, 2014
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
SEC Investigating Valeant Pharmaceuticals International, Pershing Square’s Hostile Takeover Bid For Allergan Inc.
August 15, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Allergan Inc. Claims Bill Ackman, Valeant Pharmaceuticals International Hatched Improper Insider Trading Scheme
August 4, 2014
 · 
2 min read
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
BioCapital
Insiders Reveal Valeant Pharmaceuticals International’s Cost Cutting May Have Gone Too Far
July 31, 2014
 · 
1 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More